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ABSTRACT
Trans-lesion DNA synthesis (TLS) is a DNA
damage-tolerance mechanism that uses low-fidelity
DNA polymerases to replicate damaged DNA. The in-
herited cancer-propensity syndrome xeroderma pig-
mentosum variant (XPV) results from error-prone TLS
of UV-damaged DNA. TLS is initiated when the Rad6/
Rad18 complex monoubiquitinates proliferating cell
nuclear antigen (PCNA), but the basis for recruitment
of Rad18 to PCNA is not completely understood. Here,
we show that Rad18 is targeted to PCNA by DNA poly-
merase eta (Polg), the XPV gene product that is
mutated in XPV patients. The C-terminal domain of
Polg binds to both Rad18 and PCNA and promotes
PCNA monoubiquitination, a function unique to Polg
among Y-family TLS polymerases and dissociable
from its catalytic activity. Importantly, XPV cells ex-
pressing full-length catalytically-inactive Polg exhibit
increased recruitment of other error-prone TLS poly-
merases (Poli and Poli) after UV irradiation. These
results define a novel non-catalytic role for Polg in
promoting PCNA monoubiquitination and provide a
new potential mechanism for mutagenesis and
genome instability in XPV individuals.
INTRODUCTION
Living organisms are constantly exposed to ubiquitous
genotoxins from endogenous and external sources (1).
However, cells have evolved numerous DNA damage
response (DDR) pathways that protect genomic DNA
and prevent genetic instability (2). Trans-lesion synthesis
(TLS) is a DDR mechanism involving specialized DNA
polymerases that can replicate damaged DNA templates (3).
TLS relies on inherently error-prone DNA polymerases of
the Y family to replicate damaged DNA (4). TLS by
Y-family polymerases (PolZ, Poli, Polk and Rev1) (5) main-
tains replication in cells harbouring damaged DNA, albeit at
the cost of reduced fidelity. Each TLS polymerase performs
relatively error-free replication past a preferred cognate
lesion; in the absence of the appropriate TLS polymerase
for its preferred lesion, mutagenic replication by error-prone
polymerases predisposes to genetic instability (2).
PolZ is unique among Y-family polymerases in its
ability to perform accurate replication past UV-damaged
DNA (6,7). Lack of PolZ in the inherited cancer-
propensity syndrome xeroderma pigmentosum variant
(XPV) (8) results in error-prone replication by other
Y-family polymerases in sunlight-exposed cells (9,10).
Thus, UV-induced mutagenesis due to PolZ deficiency
compromises genetic integrity to manifest as exquisite
sunlight sensitivity and early skin cancer propensity.
A prerequisite for error-prone replication in TLS is the
Rad6/Rad18-mediated monoubiquitination of prolifer-
ating cell nuclear antigen (PCNA) at the highly conserved
lysine K164 (11,12). Y-family polymerases contain
ubiquitin-binding (UBZ) domains that confer affinity to
monoubiquitinated PCNA (13,14). Failure to mono-
ubiquitinate PCNA at K164 phenocopies XPV by
compromising TLS and sensitizing cells to UV light and
other ubiquitous genotoxins (15–18). Several other DDR
pathways also depend on PCNA monoubiquitination,
including SHPRH/HTLF-mediated template switching
(19), ZRANB3-dependent replication fork restart (20),
SNM1A-dependent intrastrand cross-link repair (21) and
the Fanconi Anaemia pathway activation (22).
Despite its pivotal role in the DDR, the molecular
mechanisms regulating Rad18-mediated PCNA mono-
ubiquitination are incompletely understood. The Rad18–
Rad6 complex is thought to be recruited to the vicinity of
damaged DNA via direct interactions with RPA-coated
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ssDNA (23,24). However, Rad18 lacks PCNA-binding
motifs, and it is unclear how Rad18 is targeted specifically
to PCNA at stalled forks (or other sites of post-replication
repair). A recent report by Zou and colleagues (25)
identified Spartan as a binding partner of both Rad18
and PCNA and proposed that Spartan acts as a scaffold
for recruiting Rad18 to PCNA. Consistent with a role for
Spartan in targeting Rad18 to PCNA, those workers
found DNA damage-induced PCNA monoubiquitination
was modestly attenuated in Spartan-depleted cells.
However, several other more recent publications have
reported alternative roles for Spartan in DNA damage
signalling (26–29), and it is unclear whether Spartan or
alternative putative mediators exist to facilitate recruit-
ment of Rad18 to PCNA.
In mammalian cells, Rad18 exists in complex with PolZ
(30,31), and association of Rad18 with PolZ is necessary
for normal DNA damage tolerance (30–32). Assembly of
the Rad18–PolZ complex is stringently controlled by Cdc7
and Chk1 kinases, which serve to integrate TLS with
S-phase progression and the S-phase checkpoint, respect-
ively (30,32). Here we report that the PolZ–Rad18 inter-
action plays a key role in targeting Rad18 to PCNA
and facilitating efficient PCNA monoubiquitination.
Interestingly, the novel role of PolZ in stimulation of
PCNA monoubiquitination is fully dissociable from its
activity as a DNA polymerase. We show that the PolZ–
Rad18 interaction provides the basis for coupling PCNA
monoubiquitination with DNA damage-inducible check-
point pathways mediated by p53 and Chk1. Our results
also provide a potential explanation for numerous reports
that PolZ confers tolerance of non-cognate lesions (33,34)
and that catalytically inactive PolZ can partially rescue the
DNA damage-sensitivity phenotypes of XPV cells (35,36).
Moreover, because some XPV cells express a catalytically
inactive PolZ that retains the ability to promote PCNA
monoubiquitination, our results also indicate a new
molecular mechanism for the mutagenesis and cancer
propensity of XPV patients.
MATERIALS AND METHODS
Cell culture and transfection
H1299, HDF, XP115LO [GM02359(37,38)] and HCT-116
WT and Rad18/ cells (39) were cultured in Dulbecco’s
modified Eagle medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and penicillin–strepto-
mycin. SiRNA and pcDNA, pACCMV and pCAGGS
plasmid transfections were done using Lipofectamine
2000 (Invitrogen) as previously described (30).
Materials, siRNA, plasmid and adenovirus construction
siRNA oligonucleotide sequences were as follows:
non-targeting Control, 50–UAGCGACUAAACACAUC
AAUU–30; PolZ, 50–GCAGAAAGGCAGAAAGUUA–
30; PolZ-30 UTR, 50–CCAUUUAGGUGCUGAGUUA–
30; PolZ-50 UTR, 50–GAAUAAAUCUCGCUCGAAA–
30; Chk1, 50–GCGUGCCGUAGACUGUCCA–30;
USP1, 50–TCGGCAATACTTGCTATCTTA–30; Polk,
50–GUAAAGAGGUUAAGGAAA–30; Rad18 30 UTR,
50–UUAUAAAUGCCCAAGGAAAUU–30; Spartan 50–
ACCGGACUUGCAGGCACUGUUUGUU–30. CFP
was cloned onto the C-terminus of Rad18 in pACCMV
using BamH1 and Xba1 restriction sites. Rad18 and CFP
were separated by a linker of the sequence 50–ACCTCTT
CCGGTTCCAGTCCCTGTTCCGGGTCCTGCTCCT
ATGCGTATGGCTCC–50. Rad18-(402–445) and
Rad18-C28F were generated as described previously (31)
and cloned into pACCMV using EcoRI and BamHI re-
striction sites. PolZ-PCNA-interacting peptide (PIP)
was cloned into pACCMV using EcoRI and BamHI re-
striction sites and a C-terminal primer containing phenyl-
alanine to alanine mutations at AA 705 and 707.
Catalytically inactive PolZ was generated by mutating
codons D13, E22, D115 and E116 to alanine in the
N-terminal catalytic active site to disrupt coordination
of Mg2+ ions between dNTP, primer and active site
moieties and block nucleotide incorporation(40); this con-
struct was then cloned into pACCMV using EcoRI and
BamHI restriction sites. N-terminal PolZ truncations were
generated with 50 and 30 primers containing EcoRI and
BamHI restriction sites, respectively, and cloned into
pACCMV. The Rad18–PolZ fusion was constructed by
PCR amplification of PolZ with primers containing 30
BamHI and 50 XbaI restriction sites, followed by
ligation into pACCMV-Rad18. PolZ-PLTH and
Polk+PLTH were generated with C-terminal primers
omitting or adding, respectively, codons for the PLTH
domain, followed by a BamHI restriction site for
ligation into pACCMV. pDEST-SFB-Spartan was
obtained from Lee Zou (MGH Cancer Center).
Adenovirus constructions were performed by recombin-
ation of pACCMV constructs with pJM17 as described
previously (41).
Adenoviral expression and titration
Adenoviral infection was performed as described previ-
ously by adding to cultured cells CsCl-purified adenovirus
(41). Infections in H1299 cells were typically done at 0.1–
1.0 109 pfu/ml and in XPV/HDF cells at 0.1–5.0 109
pfu/ml. Titration to expression levels approximately equal
to endogenous was done by serial infections followed by
immunoblotting of extracts with antibodies against the
endogenous protein.
Fluorescence microscopy
H1299 or XPV cells were grown to 60% confluency on
glass-bottom plates (Mat-tek) and then infected with
adenovirus (CFP-Rad18-WT, YFP-PolZ, GFP-Polk and
respective mutants) to achieve expression approximately
equal to endogenous as determined by Western blot. For
co-expression and knockdown experiments, co-infection
or transfection was performed 6 h before adenoviral infec-
tion. Twenty hours after infection, cells were exposed
to genotoxins and then prepared for live or fixed-cell
imaging on a Zeiss 710 confocal microscope. For high-
magnification representative images, Z-stacks at 0.5-mm
intervals were collected throughout the entire cell
volume using a 63 oil-immersion objective and 2.3
optical zoom. 3D projections of Z-stacks were performed
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using Grouped Zprojector on ImageJ. For cells expressing
multiple chromophores (YFP and CFP-tagged proteins),
appropriate excitation lasers, laser intensities and emission
filter bandwidths were selected to eliminate bleedthrough.
For live-cell imaging, cells were kept out of the incubator
for no more than 10 min. For fixed-cell imaging, H1299
cells were washed 3 with cold phosphate-buffered saline
(PBS), then extracted for 60 s in cold CSK buffer, washed
3 with PBS, then fixed for 10min in 2% PFA in PBS;
XPV cells were washed 3 in cold PBS and then fixed for
15min in methanol at 20C. Post-fixation, all cells were
covered with Vectashield Solution (Vector Laboratories)
and imaged within 24 h. For foci quantification, five rep-
resentative images containing 60 cells were captured
using 0.5 mm Z-stacks with a 40 using oil-immersion
lens. After 3D projection, the number of cells clearly con-
taining >100 nuclear foci were counted as a fraction of
total chromophore-expressing cells.
Triton extraction, immunoprecipitation and
immunoblotting
Extracts containing soluble and chromatin-associated
proteins were prepared as previously described (30) by
lysing cultured cells into cold cytoskeleton buffer (CSK
buffer; 10mM Pipes, pH 6.8, 100mM NaCl, 300mM
sucrose, 3mM MgCl2, 1mM EGTA, 1mM DTT,
0.1mM ATP, 1mM Na3VO4, 10mM NaF and 0.1%
Triton X-100) supplemented with phosphatase and
protease inhibitors (Roche Diagnostics, Indianapolis,
IN, USA). For immunoprecipitation of whole cell lysate
(WCL) or chromatin-bound proteins, Triton-insoluble
proteins were released by sonication on ice for three 10-s
intervals followed by centrifugation at 15 k g for 10min.
After normalizing to a protein concentration of 1 mg/ml,
immunoprecipitation was conducted at 4C by rotating
overnight with HA-coupled or primary antibody-bound
sepharose beads (Roche Diagnostics, Indianapolis, IN,
USA). After immunoprecipitation, the beads were
washed five times for 15min in CSK buffer and then re-
suspended in minimum volume of Laemmli buffer. For
immunoblot experiments, cell extracts or immunopre-
cipitates were separated by SDS-PAGE, followed by incu-
bation overnight with the following primary antibodies:
PCNA (sc-56), Chk1 (sc-7898), b-Actin (sc-130656), all
from Santa Cruz Biotech (Santa Cruz, CA, USA); PolZ
(A301–231A), Polk (A301–975A), Poli (A301–304A) and
R18 (A301–340A), all from Bethyl Laboratories
(Montgomery, TX, USA); and p53 (Ab-6) from Lab
Vision (Fremont, CA, USA).
Genotoxin treatments
UV irradiation and benzo(a)pyrene diolepoxide (BPDE)
treatment were performed as previously described (30),
and BPDE (National Cancer Institute Carcinogen
Repository) was dissolved in anhydrous Me2SO and
added directly to the growth medium as a 1000 stock
to give various final concentrations, as indicated in the
figure legends. For UVC treatment, the growth medium
was removed from the cells, reserved and replaced with
PBS. The plates were transferred to a UV cross-linker
(Stratagene, Santa Clara, CA, USA) and then irradiated.
The UVC dose delivered to the cells was confirmed with a
UV radiometer (UVP BioImaging Systems, Upland, CA,
USA). The reserved medium from the cells was replaced,
and cells were returned to the incubator.
In vitro binding and ubiquitination assays
C-His6-PCNA-expressing Top10 Escherichia coli
(acquired from Marila Cordiero-Stone, UNC-CH) were
collected and lysed in pH 8 buffer containing 50mM
NaPO4, 300mM NaCl, 20mM imidazole and 0.1%
Triton-X. After sonication and clarification, His6-PCNA
was purified over Ni-NTA beads. For His6-PCNA
pulldown experiments, HA-Rad18 was adenovirally ex-
pressed in H1299 cells alone or together with YFP-PolZ
and lysed in NaPO4/NaCl/imidazole/Triton-X buffer.
After sonication, clarification and normalization to a
protein concentration of 1 mg/ml, cell lysates were rotated
overnight at 4C with His6-PCNA on Ni-NTA beads. The
beads were then washed five times in the same buffer
before addition of Laemmli buffer, boiling and analysis
by SDS-PAGE/Western Blot. For in vitro ubiquitination
assays, H1299 cells expressing HA-Rad18 alone or
together with YFP-PolZ were lysed in NaPO4/NaCl/imid-
azole/Triton-X buffer and immunoprecipitated with
HA-sepharose beads. After washing the beads extensively,
the beads were resuspended in 50 ml buffer and the follow-
ing were added: His6-PCNA (eluted from Ni-NTA beads
with the same buffer plus 200mM imidazole), 500 mM
FLAG-ubiquitin, 10 Energy Regeneration Solution
and 100 nM Ubiquitin Activating Enzyme (UBE1), all
from Boston Biochem (Cambridge, MA, USA). After in-
cubation for 16 h at 4C, the mixture was mixed with
Laemmli buffer, boiled and analysed by SDS-PAGE and
Western Blot.
UV cytotoxicity assay
XPV or HDF cells were split into 24-well plates to a
density of 25%. Twelve hours later, the cells were
infected with empty control adenovirus or adenovirus ex-
pressing YFP-PolZ. Twenty-four hours after infection, the
cells were exposed to UV light in the presence or absence
of 1mM caffeine. After 48 h, 50mg/ml Thiazolyl Blue
Tetrazolium Bromide (MTT) (Sigma-Aldrich, St. Louis,
MO, USA) was added to each well and allowed to
incubate at 37C for 2 h. The cells were then rinsed with
PBS and dissolved in 0.5 ml DMSO. The absorbance at
570 nm was then measured for each well and normalized
to the sham-treated samples. The minimum dose of
YFP-PolZ that conferred resistance to UV light in XPV
cells (0.5 109 pfu/ml, Supplementary Figure S2) was
determined by this method and used for survival assays.
Statistics
P values for statistical significance were determined by the
unpaired Student’s t-test with a two-tailed 95% confidence
interval.
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RESULTS
Polg promotes efficient Rad18-mediated PCNA
monoubiquitination
Current models suggest that Rad18 plays proximal roles
in TLS, chaperoning PolZ to damaged chromatin and
monoubiquitinating PCNA to stably engage Y family
polymerases at sites of PRR (12,13). Unexpectedly, we
observed deficient redistribution of Rad18 to nuclear
foci (representing sites of replication stalling) in
patient-derived XPV cells (XP115LO) following UV ir-
radiation (Figure 1A and B, Supplementary Figure S1).
In PolZ-corrected XP115LO cells, Rad18 redistributed to
nuclear foci in a UV-inducible manner and co-localized
with PolZ, indicating that Rad18 redistribution to repair
foci is PolZ dependent in XP115LO cells. Similar to results
obtained with XPV cells, redistribution of Rad18 was de-
fective in PolZ-depleted H1299 cells (Figure 1C and E),
which have intact TLS and rely on PolZ for UV tolerance
(30). As shown in Figure 1D, basal and UV-induced for-
mation of Rad18 foci were dependent on PolZ, indicating
a general role for PolZ in impacting Rad18 redistribution.
We next asked whether PolZ status also affected
PCNA-directed Rad18 E3 ligase activity. PolZ-comple-
mented XPV cells exhibited higher basal and damage-
induced PCNA monoubiquitination compared with
parental XPV cells, and PolZ expression was associated
with increased chromatin binding of Rad18 (Figure 1F).
Conversely, UV-induced PCNA monoubiquitination was
compromised in PolZ-depleted normal human diploid
fibroblasts (HDF) relative to PolZ-replete controls
(Figure 1G). PolZ depletion thus partially phenocopies
the expected effect of depleting RPA (Supplemental
Figure S2), which is thought to initiate TLS by coating
ssDNA and triggering ATR/Chk1 signalling and subse-
quent PCNA monoubiquitination (42,43). Rad18 redistri-
bution and PCNA monoubiquitination were also
attenuated in PolZ-depleted cells after BPDE treatment
(Supplementary Figure S3), indicating that the effect of
PolZ on Rad18 activity is not genotoxin specific.
Next, we determined whether increased PolZ expression
affects Rad18 and PCNA monoubiquitination. When ex-
pressed in HCT-116 cells at levels ranging from 2 - to
25-fold higher than endogenous, PCNA monoubi-
quitination increased in a dose-dependent fashion with
PolZ (Figure 1H). Importantly, PCNA monoubiqui-
tination was not induced by PolZ in isogenic Rad18-null
HCT-116 cells, indicating that the effect of PolZ on
PCNA modification is Rad18 mediated (Figure 1H,
right lane).
Potentially, the stimulatory effect of PolZ expression
on PCNA monoubiquitination could result (at least in
part) from reduced PCNA de-ubiquitylation activity.
Ubiquitin-Specific Protease 1 (USP1) is the only known
PCNA-directed de-ubiquitylating (DUB) enzyme (44).
To determine whether inhibition of USP1 activity contrib-
utes to PolZ-dependent PCNA monoubiquitination, we
determined the effects of PolZ expression on PCNA modi-
fication in USP1-depleted cells. As expected, basal levels of
PCNA monoubiquitination were increased by USP1 deple-
tion (Figure 1H). However, PolZ expression further
increased PCNA monoubiquitination in cells lacking
USP1 (compare lanes 2 and 8), both basally and 2 and
8h after DNA damage. We conclude that that PolZ stimu-
lates PCNA monoubiquitination by Rad18 via USP1-
independent mechanisms. We cannot exclude the formal
possibility that PolZ-dependent PCNA monoubiqui-
tination is not mediated by reduced activity of putative al-
ternative PCNA-directed DUBs. However, the results of
Figure 1 and data presented below indicate that PolZ fa-
cilitates redistribution of Rad18 to sites of DNA damage
and promotes efficient PCNA monoubiquitination.
Rad18–Polg interaction is necessary for efficient PCNA
monoubiquitination
Because Rad18 and PolZ form a complex after DNA
damage (31), we next asked whether PolZ-dependent redis-
tribution of Rad18 and PCNAmonoubiquitination required
Rad18–PolZ interactions. The PolZ-binding region of
Rad18 has been mapped to amino acid (AA) residues
402–445 (Figure 2A) (31). Therefore, we determined the
effect of PolZ status on the activity of a PolZ-interaction
defective Rad18 mutant, Rad18-(402–445), that retains E3
Ub-ligase activity and other DNA repair functions (31).
Consistent with in vitro binding studies (31),
Rad18-(402–445) failed to co-immunoprecipitate PolZ
from cell lysates (Figure 2B). To test how PolZ–Rad18
binding affected subcellular Rad18 distribution, we
depleted H1299 cultures of endogenous Rad18 and
reconstituted with near-physiological levels of
siRNA-resistant CFP-Rad18-WT or CFP-Rad18-(402–
445). As shown in Figure 2C and Supplementary Figure
S4, co-expression of PolZ significantly increased basal and
damage-induced redistribution of Rad18-WT to nuclear
foci but had no effect on the redistribution of
Rad18-(402–445). In replicate cultures of Rad18-
complemented cells, PolZ-induced PCNA monoubi-
quitination was severely compromised in cells comple-
mented with Rad18-(402–445) when compared with
cells expressing Rad18-WT (Figure 2D, compare lanes 1
and 8 with 11 and 12). Therefore, PolZ–Rad18 inter-
actions are necessary for PolZ-dependent PCNA
monoubiquitination.
The stable engagement of TLS polymerases with stalled
replication forks depends on their UBZ/UBM-mediated
interactions with monoubiquitinated PCNA (12–14). As
expected, the reduced PCNA monoubiquitination in cells
complemented with Rad18-(402–445) was associated
with decreased PolZ chromatin binding (Figure 2D) and
reduced formation of PolZ nuclear foci (Figure 2E and F),
when compared with Rad18-WT-expressing cells. Thus,
Rad18-(402–445) partially recapitulates phenotypes
conferred by the E3 ubiquitin ligase-deficient Rad18-
C28F mutant (Figure 2A), including defective PCNA
monoubiquitination (Figure 2G) and reduced recruitment
of PolZ to chromatin (Figure 2E and F).
Polg–PCNA interactions drive Rad18-mediated
PCNA monoubiquitination
C-terminal PolZ truncations are the most common defect
in XPV (8,45,46), in which both the PIP box (47) and the
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Figure 1. PolZ promotes damage-induced Rad18 redistribution and PCNA monoubiquitination. (A) Representative images of CSK-extracted nuclei
from CFP-Rad18-expressing XP115LO XPV cells co-infected with empty control adenovirus or adenovirus expressing YFP-PolZ (at levels that
restore UV tolerance—see Supplementary Figure S6) and exposed to UV (10 J/m2) or sham irradiated. Scalebar=10 mm. (B) Quantification of
CFP-Rad18 foci-positive H1299 nuclei as a percentage of CFP-Rad18-expressing cells as shown in (A); *P=0.0001; **P=0.001. Error
bars=SEM. (C) Representative images of live (top) and CSK-extracted (bottom) nuclei from H1299 cells treated with non-targeting control
siRNA (left) or siRNA targeting PolZ (right) and imaged 2 h after sham or UV (10 J/m2) irradiation. Scalebar=10 microns. (D) Quantification
of CFP-Rad18 foci-positive nuclei as a percentage of CFP-Rad18-expressing cells as shown in (D). *P=0.001; **P=0.0003. (E) Immunoblot of
fractionated lysates from H1299 cells expressing CFP-tagged Rad18 as shown in (D) and treated with non-targeting control siRNA or siRNA against
PolZ and then lysed 2 h after treatment with 10 J/m2 UV or sham treated. (F) Immunoblot of fractionated lysates from XP115LO XPV cells treated
with empty control adenovirus or adenovirus expressing YFP-PolZ at levels shown in (A) and lysed 2 h after treatment with 10 J/m2 UV. (G)
Immunoblot of fractionated lysates from HDF cells treated with non-targeting control siRNA or siRNA against PolZ and then lysed 2 h after
treatment with 10 J/m2 UV or sham irradiation. (H) Immunoblot of fractionated lysates from HCT-116 WT cells (lanes 1–4) or RAD18/ cells (lane
5) treated with increasing titers of YFP-PolZ adenovirus and lysed 24 h post-infection. Upper and lower arrows denote YFP-tagged and endogenous
PolZ, respectively. (I) Immunoblot of fractionated lysates from H1299 cells expressing empty control adenovirus or adenovirus expressing YFP-PolZ
and treated with non-targeting control siRNA or siRNA against USP1 and then lysed at indicated times after treatment with 200 nM BPDE. On all
Western blots, asterisk denotes monoubiquitinated PCNA and bar graphs represent intensity of monoubiquitinated PCNA band relative to the
maximum band on each film.
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Figure 2. Physical interaction between Rad18 and PolZ drives efficient damage-induced PCNA ubiquitination. (A) Schematic of Rad18-WT (top);
Rad18-(402–445), a PolZ-binding deficient mutant lacking the PolZ binding domain (AA 402–445); Rad18-C28F, an E3 ligase-inactive mutant in
which the RING-finger cysteine has been substituted with phenylalanine. (B) Immunoblot analysis of anti-HA immunoprecipitates from H1299 cells
co-expressing HA-Rad18-WT or HA-Rad18-(402–445) with Myc-PolZ. (C) Quantification of CFP-Rad18 foci-positive nuclei as a percentage of
H1299 cells expressing CFP-Rad18-WT or CFP-Rad18-(402–445) and treated with empty adenovirus or Myc-PolZ-expressing adenovirus followed
by UV (10 J/m2) treatment or sham irradiation. *P=0.095; **P=0.0006. Error bars=SEM. (D) Immunoblots of fractionated lysates from
Rad18-depleted H1299 cells that were reconstituted with siRNA-resistant Rad18-WT, Rad18-(402–445), or empty vector (for control) alone or
together with FLAG-PolZ, followed by treatment with UV (10 J/m2) or sham-irradiation. (E) Representative images of CSK-extracted nuclei from
YPF-PolZ expressing H1299 cells that were depleted of endogenous Rad18 and then reconstituted with siRNA-resistant Rad18-WT, or
Rad18-(402–445), or Rad18-C28F and treated with UV (10 J/m2) or sham irradiated. Scalebar=10 um. (F) Quantification of YFP-PolZ
foci-positive nuclei as a percentage of YFP-PolZ-expressing cells in cultures complemented with Rad18-WT, Rad18-(402–445), or Rad18-C28F
as shown in (E). *upper P=0.026, lower P=0.0238. (G) Immunoblots of fractionated lysates from Rad18-depleted H1299 cells that were
reconstituted with siRNA-resistant WT-Rad18, C28F-Rad18, or empty vector, and then treated with UV (10 J/m2) or sham irradiated.
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Rad18-binding domains (31) are deleted. To test whether
PolZ XPV C-terminal truncation mutants exhibit defects
in Rad18 regulation, we complemented XPV cells with
WT-PolZ or similar levels of a common XPV PolZ
mutant that retains full catalytic activity (48) but fails to
confer UV resistance [PolZ-(1–512), lacking residues
513–713, Figure 3A]. As expected, complementation of
XPV cells with PolZ-WT conferred normal Rad18 redis-
tribution (Figure 3B and C) and resulted in increased
PCNA monoubiquitination (Figure 3D). However, com-
plementation of XPV cells with PolZ-(1–512) failed to
restore Rad18 redistribution or PCNA monoubiqui-
tination to the same extent as those complemented with
PolZ-WT (Figure 2B–D), indicating that the C-terminal
domain of PolZ is important not only for PolZ chromatin
binding, but also for Rad18 nuclear redistribution and
Rad18-mediated PCNA monoubiquitination.
To test whether loss of PCNA binding contributes to de-
fective PCNA monoubiquitination in PolZ-(1–512)-com-
plemented XPV cells, we generated point mutations in the
PIP box that abrogate PCNA binding (47) (Figure 3A). In
Rad18-depleted cells complemented with physiological levels
of Rad18-WT, PolZ-WT, but not PolZ-PIP, promoted
PCNA monoubiquitination by Rad18 (Figure 3E,
compare lanes 7 and 8 with 11 and 12). Therefore, PolZ–
PCNA association via the PIP box of PolZ contributes to
maximal Rad18-mediated PCNA monoubiquitination.
Polg scaffolding mediates Rad18–PCNA association
Although PolZ possesses a PIP box (47,49) and interacts
directly with PCNA (47), no PCNA-interacting domain has
been identified for Rad18, and the mechanism for associ-
ation of Rad18 with PCNA is unknown. The PolZ depend-
ence of Rad18-mediated PCNA monoubiquitination
(Figures 1–3) suggested that PolZmay serve as a ‘molecular
bridge’ or scaffold to facilitate Rad18–PCNA interactions.
To test this hypothesis, we developed a cell-free system to
determine the PolZ dependence of PCNA–Rad18 inter-
actions (if any). Recombinant PCNA was immobilized on
Ni-NTA beads (or unloaded beads for controls) and
incubated with extracts from cells expressing Rad18 alone
or in combination with PolZ. When extracts from
Rad18-expressing cells were incubated with PCNA-Ni
beads, we were unable to detect association between
Rad18 and PCNA (Figure 3F, lane 1). However, we
readily detected Rad18 association with immobilized
PCNA incubated with lysates from Rad18 and PolZ
co-expressing cultures (Figure 3F, lane 2). Therefore, we
conclude that PolZ promotes Rad18–PCNA interactions
or stabilizes Rad18–PCNA complexes.
We modified this cell-free assay to test whether the
presence of PolZ influenced PCNA monoubiquitination
by Rad18. HA-Rad18 was expressed in UV-irradiated
H1299 cells individually or in combination with PolZ and
then immunoprecipitated using anti-HA antibodies. The
resulting immune complexes were then mixed with recom-
binant PCNA, E1, FLAG-ubiquitin and an ATP-
regenerating system. As shown in Figure 3G, Rad18
immune complexes conjugated FLAG-ubiquitin to PCNA
in a manner that was stimulated by PolZ (compare lanes
2 and 3).
Taken together, the results of Figure 3 suggest that PolZ
promotes efficient PCNA monoubiquitination via a
bridging mechanism that facilitates physical interaction
between Rad18 and PCNA.
Polg-induced PCNA monoubiquitination is dissociable
from catalytic activity
To test whether DNA polymerase activity was required for
PolZ to promote PCNA monoubiquitination, we generated
a PolZ mutant harbouring four inactivating point substitu-
tions in conserved residues necessary for catalytic activity
(40) (Figure 4A). Catalytically inactive mutant PolZ
(PolZ-C.I.) and wild-type PolZ both stimulated PCNA
monoubiquitination to similar levels (Figure 4B).
Additionally, PolZ-C.I. caused Rad18 redistribution to
nuclear foci in a manner nearly identical to PolZ-WT
(Figure 4C and D). Thus, the function of PolZ in
promoting Rad18-mediated PCNA monoubiquitination is
dissociable from its catalytic role as a DNA polymerase.
To probe the molecular determinants of PCNA
monoubiquitination induced by PolZ, we performed
structure–function studies using PolZ truncation mutants
that progressively eliminated AAs 1–400 spanning the
catalytic domain (Figure 4A). Interestingly, when ex-
pressed at equal levels, the PolZ-truncation mutants
mobilized Rad18 to nuclear foci in a manner similar to
PolZ-WT (Figure 4E). A PolZ truncation constituting
only 300C-terminal amino acids induced a level of
PCNA monoubiquitination comparable with WT-PolZ
(Figure 4F). Therefore, the Rad18- and PCNA-binding
C-terminus of PolZ represents the minimal domain that
is necessary and sufficient to regulate Rad18 activity and
promote PCNA monoubiquitination.
Recent work identified a novel PIP box and
UBZ-containing protein termed ‘Spartan’ that promotes
PCNA monoubiquitination via a bridging mechanism
between PCNA and Rad18, similar to that which we
have defined for PolZ (25). To compare the relative con-
tribution of Spartan and PolZ to Rad18-mediated PCNA
monoubiquitination, we expressed FLAG-PolZ or
FLAG-Spartan in H1299 cells. When expressed at com-
parable levels, PolZ induced an increase in PCNA
monoubiquitination that was nearly 10-fold higher than
that conferred by Spartan (Figure 4G) and siRNA-
mediated knockdown of PolZ decreased UV-induced
PCNA monoubiquitination significantly more than
Spartan knockdown (Supplementary Figure S5, compare
lanes 4 and 6). Together, these data indicate that scaffold-
ing of PCNA and Rad18 by PolZ plays an important role
in the regulation of PCNA monoubiquitination.
Y family polymerase specificity of Polg-dependent
PCNA monoubiquitination
We next asked whether the stimulatory effect of PolZ on
Rad18 activity was shared by other Y-family TLS polymer-
ases. Similar to PolZ, Polk associates with Rad18 (41), re-
distributes to form nuclear foci in response to DNA
damage, and associates with PCNA via C-terminal PIP
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box. Therefore, for the purpose of comparison with PolZ,
we determined the effects of manipulating Polk expression
levels on PCNAmonoubiquitination. In contrast with PolZ
knockdown, Polk depletion did not attenuate PCNA
monoubiquitination basally or after genotoxin treatment
(Figure 5A). Even when expressed at levels 15-fold
higher than PolZ, Polk did not induce the robust PCNA
monoubiquitination response elicited by PolZ (Figure 5B).
Polk also induced far less Rad18 redistribution to chroma-
tin. Hence, the role of PolZ in promoting genotoxin-
induced PCNA monoubiquitination is not shared by all
Y-family TLS polymerases.
Figure 3. PolZ physically bridges Rad18 and PCNA to promote efficient PCNA monoubiquitination after DNA damage. (A) Schematic of PolZ-WT
(top); PolZ-(1–512), a C-terminal truncation lacking AA 513–713 (middle); and PolZ-PIP, full length PolZ with two PIP box phenylalanines
mutated to alanine (bottom). (B) Representative images of CSK-extracted nuclei from XPV cells that were co-infected with CFP-Rad18 and
YFP-PolZ-(1–512) adenovirus (left) or YFP-PolZ-WT (right) and treated with UV (10 J/m2) or sham irradiated. Scalebar=10 um.
(C) Quantification of CFP-Rad18 foci-positive nuclei as a percentage of CFP-Rad18-expressing XPV cells expressing YFP-PolZ-(1–512) or
YFP-PolZ-WT adenovirus. *upper P=0.018; **P=0.0001; Error bars=SEM. (D) Immunoblots of fractionated lysates from XPV cells comple-
mented with PolZ-WT or PolZ-(1–512) and treated with 10 J/m2 UV. (E) Immunoblots of fractionated lysates from Rad18-depleted H1299 cells
that were reconstituted with siRNA-resistant Rad18-WT together with FLAG-tagged PolZ-WT or PolZ-PIP and treated with sham or 10 J/m2 UV.
(F) In vitro pulldown assay. His6-PCNA-loaded Nickel beads (or unloaded beads) were incubated with lysates from UV-irradiated H1299 cells
expressing HA-Rad18 or both HA-Rad18 and YFP-PolZ. (G) In vitro ubiquitination assay. HA-Rad18 complexes immunoprecipitated from
UV-irradiated H1299 cells expressing HA-Rad18 alone or in combination with YFP-PolZ were mixed with recombinant His6-PCNA, E1,
FLAG-ubiquitin, and an ATP-regenerating system and conjugated FLAG-Ub was detected by immunoblotting with anti-FLAG antibodies.
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Figure 4. Physical bridging of Rad18 and PCNA by PolZ is dissociable from its DNA polymerase activity. (A) Schematic of PolZ-WT (top);
full-length catalytically inactive PolZ, PolZ-C.I, in which amino acids D13, E22, D115 and E116 are mutated to alanine; and N-terminal PolZ
truncation mutants, PolZ-(301–713) and PolZ-(401–713). (B) Immunoblots of fractionated lysates from Myc-PolZ-WT or Myc-PolZ-C.I.-ex-
pressing H1299 cells that were treated with UV (10 J/m2) or sham irradiated. (C) Representative images of CSK-extracted nuclei from H1299 cells
that were co-infected with CFP-Rad18 and empty control adenovirus (left), Myc-PolZ-WT (middle) or Myc-PolZ-C.I. (right) and treated with UV
(10 J/m2) or sham irradiated. Scalebar=10 um. (D) Quantification of CFP-Rad18 foci-positive nuclei as a percentage of CFP-Rad18-expressing
H1299 cells expressing empty control adenovirus, Myc-PolZ-WT or Myc-PolZ-C.I. **P=0.0016; *P=0.0287; Error bars=SEM.
(E) Quantification of CFP-Rad18 foci-positive nuclei as a percentage of CFP-Rad18-expressing H1299 cells expressing empty control adenovirus,
Myc-PolZ-WT, Myc-PolZ-(301–713) or Myc-PolZ-(401–713). Error bars=SEM. (F) Immunoblot of fractionated lysates from H1299
cells expressing empty control adenovirus, Myc-PolZ-WT, Myc-PolZ-(301–713) or Myc-PolZ-(401–713). (G) Immunoblot of fractionated
lysates from H1299 cells expressing empty vector control, FLAG-PolZ or FLAG-Spartan and lysed 2 h after treatment with 10 J/m2 UV or
sham treatment.
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Figure 5. High-affinity interaction with PCNA drives PolZ-specific induction of PCNA monoubiquitination. (A) Immunoblot of fractionated lysates
from control or Polk-depleted H1299 cells that were lysed 2 h after treatment with UV (10 J/m2) or sham irradiation. (B) Immunoblot of fractionated
lysates from H1299 cells expressing YFP-PolZ or GFP-Polk and lysed 2 h after treatment with UV (10 J/m2) or sham irradiated. (C) Sequence of the
C-terminus of PolZ and Polk and the mutants used in domain-swap experiments: PolZ-PLTH and Polk+PLTH. PIP-box consensus amino acids
are in bold, where c=I/L/M; y=Y/F. (D) Representative images of CSK-extracted nuclei from H1299 cells that were infected with GFP-Polk-WT,
GFP-Polk+PLTH, YFP-PolZ-WT or YFP-PolZ-PLTH and treated with 10 J/m2 UV or sham irradiated. Scalebar=10 mm. (E) Quantification of
foci-positive nuclei as a percentage of H1299 cells expressing in YFP-PolZ-WT, YFP-PolZ-PLTH, GFP-Polk-WT or GFP-Polk+PLTH.
3088 Nucleic Acids Research, 2013, Vol. 41, No. 5
(continued)
Because PolZ and Polk both associate with Rad18 after
DNA damage (30,41), differences in Rad18 binding do
not explain the inability of Polk to promote PCNA
monoubiquitination. We therefore hypothesized that dif-
ferences in TLS polymerase–PCNA binding account for
the differential contributions of PolZ and Polk to PCNA
monoubiquitination. Domains flanking the PIP boxes in
the various Y family members confer dramatically differ-
ent PCNA-binding affinities (49); specifically, the high
PCNA-binding affinity of PolZ relative to other TLS poly-
merases is attributed in large part to the ‘PLTH’ sequence
immediately C-terminal to its PIP box (Figure 5C).
To test whether PCNA-binding affinity influences
relative PCNA monoubiquitination activity, we per-
formed domain-swap experiments in which we removed
the PLTH motif from PolZ (generating PolZ-PLTH)
or added it to Polk (generating Polk+PLTH)
(Figure 5C). We then compared the subcellular distribu-
tion of wild-type and mutant forms of PolZ and Polk. As
expected, PolZ-PLTH showed reduced nuclear focus
formation and was also compromised for PCNA
monoubiquitination activity relative to PolZ-WT
(Figure 5D and F). Conversely, whereas Polk-WT was
localized diffusely throughout the nucleus, Polk+PLTH
showed a focal distribution pattern more similar to that
of PolZ-WT. Interestingly, Polk+PLTH induced more
robust PCNA monoubiquitination than Polk-WT
(Figure 5F), demonstrating that addition of the PLTH
(from the PolZ PIP) to the Polk PIP increases its ability
to induce PCNA monoubiquitination. Therefore, high
affinity binding of PolZ to PCNA confers the unique
ability among Y-family polymerases to promote PCNA
monoubiquitination.
DNA damage-induced PCNA monoubiquitination con-
tributes to the PCNA binding of all Y-family TLS poly-
merases (11–13). We hypothesized that PolZ would
influence other Y-family TLS polymerases by facilitating
PCNA monoubiquitination, independently of its catalytic
activity. Therefore, we compared the UV-inducible redis-
tribution of Poli and Polk in parental XPV cells or XPV
cells reconstituted with PolZ-WT or PolZ-C.I. Consistent
with prior studies (50,51), we found that basal and
UV-induced Poli and Polk redistribution to nuclear foci
was higher in PolZ-WT-reconstituted XPV cells compared
with the PolZ-defective parental cell line (Figure 5G
and H). Importantly, we found that PolZ-C.I. dramatic-
ally increased both basal and UV-induced redistribution
of Poli and Polk to nuclear foci. We conclude that cells
expressing full-length catalytically inactive PolZ retain
Rad18-stimulatory activity, which in turn promotes re-
cruitment of alternative error-prone polymerases to
stalled replication forks.
p53 promotes PCNA monoubiquitination via
transcriptional induction of Polg
Because Rad18-mediated PCNA monoubiquitination was
sensitive to PolZ expression, it was of interest to determine
relative levels of Rad18 and PolZ within cells. Therefore,
we expressed an in-frame fusion of full-length PolZ and
full-length Rad18 in cultured cells, which allowed us to
perform quantitative comparison of each endogenous
protein relative to the Rad18–PolZ fusion (Figure 6A)
using appropriate antibodies.
At expression levels comparable with endogenous PolZ,
the Rad18–PolZ fusion protein was nearly undetectable in
immunoblots with anti-Rad18 antibody (Rad18 light),
and prolonged exposures revealed that expression of the
fusion at these levels was substantially lower than en-
dogenous Rad18 (Rad18 dark). This surprising result
demonstrated that cellular Rad18 protein expression is
several orders of magnitude higher than PolZ in human
cells; we estimate that Rad18 expression exceeds PolZ by
75-fold. Importantly, expression of the Rad18–PolZ
fusion protein to a level double that of endogenous PolZ
(and negligible compared with endogenous Rad18)
induced a 6-fold increase in PCNA monoubiquitination
(right lane), showing that Rad18-mediated PCNA
monoubiquitination is highly sensitive to PolZ levels.
These findings prompted us to determine whether physio-
logically relevant changes in PolZ expression influence
PCNA monoubiquitination.
POLH is a transcriptional target of activated p53, and
DNA damage stimulates p53-dependent increases in PolZ
protein expression (52). Because endogenous PolZ levels are
limiting for Rad18 activity, we hypothesized that p53-
induced PolZ expression contributes to PCNA monoubi-
quitination. Therefore, we compared UV-induced PCNA
monoubiquitination in WT HCT-116 cells and an isogenic
p53-null HCT-116 line (Figure 6B). As expected, PolZ
protein levels were lower in p53-null cells (compared with
WT) after UV. Interestingly, PCNA was monoubi-
quitinated after UV treatment in a manner that was tem-
porally co-incident with PolZ expression in p53-expressing
HCT-116 cells, but not in p53/ cells.
To test whether the p53-induced PCNA monoubi-
quitination was PolZ dependent, we depleted PolZ in
p53-null H1299 cells that were transfected with empty
vector or pcDNAp53. As shown in Figure 6C, transient
expression of p53 led to concomitant increases in PolZ
expression and UV-induced PCNA monoubiquitination
(compare lanes 1 and 2 with 5 and 6). Importantly, PolZ
depletion severely impaired PCNA monoubiquitination in
p53-expressing cells compared to controls. Therefore, the
Figure 5. Continued
*left P=0.0001; **P=0.0004; Error bars=SEM. (F) Immunoblot of fractionated lysates from H1299 expressing YFP-PolZ-WT,
YFP-PolZ-PLTH, GFP-Polk-WT or GFP-Polk+PLTH. (G) Representative images of CSK-extracted nuclei from XPV cells that were co-infected
with CFP-Poli or GFP-Polk and empty control adenovirus (left), Myc-PolZ-WT (middle) or Myc-PolZ-C.I. and treated with UV (10 J/m2) or sham
irradiated. Scalebar=10 mm. (H) Quantification of CFP-Poli foci-positive nuclei as a percentage of CFP-Poli-expressing XPV cells (left) and
GFP-Polk foci-positive nuclei as a percentage of GFP-Polk-expressing XPV cells (right), after co-infection with empty control adenovirus,
Myc-PolZ-WT or Myc-PolZ-C.I. and treatment with UV (10 J/m2) or sham irradiation. *left P=0.0009; **P=0.0004, *right P=0.0022; Error
bars=SEM.
Nucleic Acids Research, 2013, Vol. 41, No. 5 3089
p53-dependent component of PCNA monoubiquitination
is PolZ-mediated.
Because loss of p53 sensitizes normal fibroblasts, but
not XPV cells, to UV (53,54), we hypothesized that the
UV protection conferred by PolZ is mediated by p53. To
test this hypothesis, we compared UV survival in
p53-depleted HDF cells infected with ‘empty’ control
adenovirus or adenovirus expressing PolZ at levels that
confer UV survival in XPV fibroblasts (Supplementary
Figure S6). We found that PolZ expression modestly,
but significantly, increased UV survival in p53/ cells
(Figure 6D). Therefore, loss of p53-mediated PolZ regu-
lation indeed contributed to the UV sensitivity of p53 null
fibroblasts. Together, these results suggest that PolZ fa-
cilitates PCNA monoubiquitination in a p53-dependent
manner, thereby revealing a novel link between the p53
pathway and TLS (Figure 7).
DISCUSSION
The results described here are consistent with existing
models of TLS pathway activation involving an initial re-
distribution of the Rad18–PolZ complex to the vicinity of
damaged DNA (most likely via association of Rad18 with
RPA-coated ssDNA) (23,55). However, our results extend
current models in that we propose Rad18 is in turn
targeted to PCNA, its relevant substrate at the stalled rep-
lication fork, by PolZ (Figure 7). Specifically, the extreme
C-terminus of PolZ physically bridges Rad18 and PCNA
to stimulate PCNA monoubiquitination (Figure 3), a
function unique to PolZ among TLS polymerases and
fully dissociable from its TLS polymerase activity. The
results of this study challenge the notion that TLS consti-
tutes a simple linear pathway in which Rad18 acts
upstream of PolZ to promote TLS. Instead, we propose
that Rad18 and PolZ play mutually dependent roles in
TLS pathway activation.
Non-catalytic effector functions have been identified for
other participants of the DDR, including Rev1 (56),
Rad18 (31), NBS1 (57) and Chk1 (58), but this is the
first demonstration of a DNA polymerase-independent
activity for PolZ. A non-catalytic role for PolZ in
stimulating PCNA monoubiquitination helps explain
results of recent studies by other labs. For example,
XPV cells are hypersensitive to BPDE and other
genotoxins whose DNA lesions are not bypassed by
Figure 6. Rad18–PolZ interaction is checkpoint sensitive and p53 regulated in response to DNA damage. (A) Immunoblots of fractionated lysates
from H1299 cells transfected with increasing quantities of pACCMV-Rad18-PolZ fusion construct. (B) Immunoblot of fractionated lysates from
HCT-116 WT or HCT-116 p53/ cells that were UV treated (30 J/m2) and lysed at indicated times after irradiation. (C) Immunoblots of
fractionated lysates of H1299 cells that were transfected with empty pcDNA as control or pcDNA-p53, followed by non-targeting control
siRNA or siRNA against PolZ. Cells were lysed 6 h after 10 J/m2 UV. (D) UV sensitivity of WT or p53/ HDF incubated in 1mM caffeine
and exposed to increasing doses of UV. Cells were infected with YFP-PolZ adenovirus at a dose that confers UV survival in XP115LO cells
(see Supplementary Figure S6). **P=0.0305 at 12 J/m2. **P=0.0036 at 15 J/m2.
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PolZ (33,34); clearly, a polymerase-independent function
of PolZ that promotes PCNA monoubiquitination and
activation of Polk (the TLS polymerase that mediates
bypass of BPDE adducts) explains the BPDE sensitivity
of XPV cells. In other studies, catalytically dead PolZ
mutants conferred DNA damage tolerance (36,59) and
mutagenesis (35,36). Because PCNA monoubiquitination
at K164 is necessary for tolerance of UV and other
genotoxins (15–17), restoration of UV survival by catalyt-
ically dead PolZ (36) is explained by its scaffold function
that promotes PCNA monoubiquitination, thus recruiting
other TLS polymerases that facilitate tolerance, albeit at a
cost of increased mutagenesis.
The PolZ scaffolding function identified here has im-
portant implications for the molecular basis of genetic in-
stability in XPV patients. Mutagenesis in XPV cells is
widely believed to result solely from deficient PolZ poly-
merase activity (60), leading to error-prone TLS of
UV-damaged DNA by alternative and inappropriate
TLS polymerases (10). Many XPV mutations encode
C-terminally-truncated forms of PolZ that lack Rad18-
and PCNA-binding domains (45). However, in XPV
cells in which PolZ catalytic activity is perturbed while
Rad18-PCNA bridging activity remains intact, high rates
of UV-induced mutation frequencies may be conferred not
only by loss of thymine dimer bypass activity by PolZ, but
also by stimulation of Rad18-mediated PCNA monoubi-
quitination and recruitment of alternative error-prone
DNA polymerases.
Our finding that cellular Rad18 expression vastly
exceeds PolZ was unexpected, yet fully explains why
PCNA monoubiquitination is exquisitely sensitive to
slight alterations in PolZ levels (Figure 6). Potentially,
any process that affects PolZ expression (52), stability
(61–63), or nuclear localization (64) or its association
with Rad18 is likely to affect PCNA monoubiquitination
and in turn influence TLS. Indeed, we show here that
transcriptional induction of POLH by p53 contributes to
PCNA monoubiquitination. The PolZ-Rad18 interaction
is dependent on checkpoint signalling via Chk1 (30).
Therefore, the results of this study may explain the
long-standing observation that Chk1 signalling is
required for efficient PCNA monoubiquitination (41,58).
In fact, the Rad18-(402–445) mutant in this study that
failed to monoubiquitinate PCNA inducibly in response
to PolZ expression lacks the Chk1-dependent phosphoryl-
ation sites required for PolZ binding (30). Therefore, the
PolZ-dependent mechanism for PCNA monoubi-
quitination described here may provide the basis for cross-
talk between TLS and multiple processes including p53
signalling and the S-phase checkpoint.
Several DNA damage-tolerance pathways depend on
PCNA monoubiquitination, including replication fork
restart (20), template switching (19), intrastrand cross-link
repair (21) and the Fanconi Anaemia pathway (22).
Hence, PolZ contributes to cross-talk between multiple
DDR pathways via PCNA monoubiquitination; loss of
this element of the DDR in XPV underscores the import-
ance of their orchestrated convergence to preserve genetic
stability.
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